Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype

The interaction of tumor cells with blood vessels is one of the key steps during cancer metastasis. Metastatic cancer cells exhibit phenotypic state changes during this interaction: (1) they form tunneling nanotubes (TNTs) with endothelial cells, which act as a conduit for intercellular communicatio...

Full description

Bibliographic Details
Main Authors: Chinmayee Dash, Tanmoy Saha, Shiladitya Sengupta, Hae Lin Jang
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/11/6161
_version_ 1797531050337894400
author Chinmayee Dash
Tanmoy Saha
Shiladitya Sengupta
Hae Lin Jang
author_facet Chinmayee Dash
Tanmoy Saha
Shiladitya Sengupta
Hae Lin Jang
author_sort Chinmayee Dash
collection DOAJ
description The interaction of tumor cells with blood vessels is one of the key steps during cancer metastasis. Metastatic cancer cells exhibit phenotypic state changes during this interaction: (1) they form tunneling nanotubes (TNTs) with endothelial cells, which act as a conduit for intercellular communication; and (2) metastatic cancer cells change in order to acquire an elongated phenotype, instead of the classical cellular aggregates or mammosphere-like structures, which it forms in three-dimensional cultures. Here, we demonstrate mechanistically that a siRNA-based knockdown of the exocyst complex protein Sec3 inhibits TNT formation. Furthermore, a set of pharmacological inhibitors for Rho GTPase–exocyst complex-mediated cytoskeletal remodeling is introduced, which inhibits TNT formation, and induces the reversal of the more invasive phenotype of cancer cell (spindle-like) into a less invasive phenotype (cellular aggregates or mammosphere). Our results offer mechanistic insights into this nanoscale communication and shift of phenotypic state during cancer–endothelial interactions.
first_indexed 2024-03-10T10:38:37Z
format Article
id doaj.art-fe5adecd33fd4a078bf822d7c7e79987
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:38:37Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-fe5adecd33fd4a078bf822d7c7e799872023-11-21T23:10:30ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-012211616110.3390/ijms22116161Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic PhenotypeChinmayee Dash0Tanmoy Saha1Shiladitya Sengupta2Hae Lin Jang3Center for Engineered Therapeutics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02139, USACenter for Engineered Therapeutics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02139, USACenter for Engineered Therapeutics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02139, USACenter for Engineered Therapeutics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02139, USAThe interaction of tumor cells with blood vessels is one of the key steps during cancer metastasis. Metastatic cancer cells exhibit phenotypic state changes during this interaction: (1) they form tunneling nanotubes (TNTs) with endothelial cells, which act as a conduit for intercellular communication; and (2) metastatic cancer cells change in order to acquire an elongated phenotype, instead of the classical cellular aggregates or mammosphere-like structures, which it forms in three-dimensional cultures. Here, we demonstrate mechanistically that a siRNA-based knockdown of the exocyst complex protein Sec3 inhibits TNT formation. Furthermore, a set of pharmacological inhibitors for Rho GTPase–exocyst complex-mediated cytoskeletal remodeling is introduced, which inhibits TNT formation, and induces the reversal of the more invasive phenotype of cancer cell (spindle-like) into a less invasive phenotype (cellular aggregates or mammosphere). Our results offer mechanistic insights into this nanoscale communication and shift of phenotypic state during cancer–endothelial interactions.https://www.mdpi.com/1422-0067/22/11/6161tunneling nanotube (TNT)metastasisRhoGTPase inhibitorphenotypic plasticityexocyst complexactin remodeling
spellingShingle Chinmayee Dash
Tanmoy Saha
Shiladitya Sengupta
Hae Lin Jang
Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype
International Journal of Molecular Sciences
tunneling nanotube (TNT)
metastasis
RhoGTPase inhibitor
phenotypic plasticity
exocyst complex
actin remodeling
title Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype
title_full Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype
title_fullStr Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype
title_full_unstemmed Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype
title_short Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype
title_sort inhibition of tunneling nanotubes between cancer cell and the endothelium alters the metastatic phenotype
topic tunneling nanotube (TNT)
metastasis
RhoGTPase inhibitor
phenotypic plasticity
exocyst complex
actin remodeling
url https://www.mdpi.com/1422-0067/22/11/6161
work_keys_str_mv AT chinmayeedash inhibitionoftunnelingnanotubesbetweencancercellandtheendotheliumaltersthemetastaticphenotype
AT tanmoysaha inhibitionoftunnelingnanotubesbetweencancercellandtheendotheliumaltersthemetastaticphenotype
AT shiladityasengupta inhibitionoftunnelingnanotubesbetweencancercellandtheendotheliumaltersthemetastaticphenotype
AT haelinjang inhibitionoftunnelingnanotubesbetweencancercellandtheendotheliumaltersthemetastaticphenotype